Dr. Sharp received her undergraduate and medical degrees from the University of Michigan. She completed her Diagnostic Radiology residency at University Hospital in Cincinnati, followed by a Pediatric Radiology fellowship at Cincinnati Children's Hospital Medical Center. Her primary areas of interest are pediatric nuclear medicine and pediatric tumor imaging. Dr. Sharp is active in several national societies including the Society for Pediatric Radiology (SPR) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
BS: University of Michigan, Ann Arbor, MI, 1997.
MD: University of Michigan Medical School, Ann Arbor, MI, 2001.
Internship: William Beaumont Hospital, Royal Oak, MI, 2002.
Residency: University Hospital, Cincinnati, OH, 2006.
Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2007.
Certifications: Diagnostic Radiology, American Board of Radiology, 2006; CAQ Pediatric Radiology, American Board of Radiology, 2008.
Diagnostic and therapeutic nuclear medicine; pediatric tumor imaging
Imaging of pediatric neuroblastoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatric Blood and Cancer. 2023; 70 Suppl 4:e29974.
Imaging of pediatric bone tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatric Blood and Cancer. 2023; 70 Suppl 4:e30000.
Ultrasound determination of pediatric thyroid mass. Pediatric Radiology: roentgenology, nuclear medicine, ultrasonics, CT, MRI. 2023; 53:28-33.
Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner. American Journal of Roentgenology. 2022; 219:952-961.
072 MULTI-INSTITUTIONAL EXPERIENCE OF FENTANYL FOR BROWN FAT MITIGATION IN 18FDG-PET/CT FOR PEDIATRIC ONCOLOGY PATIENTS. Leukemia Research: clinical and laboratory studies. 2022; 121:s48.
Agreement between serum estimates of glomerular filtration rate (GFR) and a reference standard of radioisotopic GFR in children with cancer. Pediatric Radiology: roentgenology, nuclear medicine, ultrasonics, CT, MRI. 2022; 52:903-909.
Prognostic significance of pretreatment 18F-FDG positron emission tomography/computed tomography in pediatric neuroblastoma. Pediatric Radiology: roentgenology, nuclear medicine, ultrasonics, CT, MRI. 2021; 51:1400-1405.
Discrepancies between F-18-FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis. Pediatric Blood and Cancer. 2021; 68:e28891.
RESPECT: Radiology Employees Striving for Productive and Effective Communication. Radiographics : a review publication of the Radiological Society of North America, Inc. 2020; 40:2068-2079.